Leptin Levels in Papillary Thyroid Cancer

Thyroid Cancer, Papillary Clinical Trial

— LL-PTC  

Official title:

Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01659385
• Other study ID #: 0276-12-EP
• Status: Completed
• Start date: August 7, 2012
• Est. completion date: April 25, 2013

Study information

• Verified date: August 2023
• Source: University of Nebraska
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to evaluate Leptin levels in females, in the setting of papillary thyroid cancer, benign thyroid nodules, and in normal females without thyroid disease.

Description:

There will be three groups in this study, but 2 of the groups are part of another study so will only recruit normal controls.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18
• Est. completion date: April 25, 2013
• Est. primary completion date: April 25, 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 19 Years to 75 Years

Eligibility

Inclusion Criteria:

• Female

• Age>/- 19

• Not currently pregnant or lactating

• Normal thyroid gland by history

Exclusion Criteria:

• Male Gender

• Pregnancy

• Lactation

• Age below 19

• Abnormal thyroid gland by history

• Abnormal thyroid gland by structure using ultrasound

• Abnormal thyroid gland by function using TSH, Free T4

Related Conditions & MeSH terms

• Leptin Levels
• Thyroid Cancer, Papillary
• Thyroid Diseases
• Thyroid Neoplasms

Locations

Country	Name	City	State
United States	University of Nebraska Medical Center	Omaha	Nebraska

Sponsors (1)

Lead Sponsor	Collaborator
University of Nebraska

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	evaluating Leptin level Evaluating Serum Leptin Levels Between 3 Groups. One Group with Papillary Thyroid Carcinoma. One Group With Benign Nodules. One Group with Normal Thyroid.	Assessing serum leptin levels in females with treated papillary thyroid carcinoma and compared to females with proven benign thyroid nodules and females with normal thyroid glands. All groups were matched by gender, age, and BMI to limit confounders.	During Study